NovoCure (NVCR) EBITDA Margin Growth (5y) (2019 - 2026)
Powered by 
Analysis
NovoCure (NVCR) EBITDA Margin Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn |
| 10 | NovoCure | 1.88 Bn | 1.44 Bn | 142.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 346.00 |
| Mar 31, 2026 | -3,867.00 |
| Dec 31, 2025 | -3,157.00 |
| Sep 30, 2025 | -3,287.00 |
| Jun 30, 2025 | -3,064.00 |
| Mar 31, 2025 | -2,111.00 |
| Dec 31, 2024 | -3,941.00 |
| Sep 30, 2024 | -2,488.00 |
| Jun 30, 2024 | -2,371.00 |
| Mar 31, 2024 | -2,163.00 |
| Dec 31, 2023 | -2,622.00 |
| Sep 30, 2023 | -3,765.00 |
| Jun 30, 2023 | -3,819.00 |
| Mar 31, 2023 | -2,499.00 |
| Dec 31, 2022 | -2,507.00 |
| Sep 30, 2022 | -698.00 |
| Jun 30, 2022 | 2,547.00 |
| Mar 31, 2022 | 3,775.00 |
| Dec 31, 2021 | 4,155.00 |
| Sep 30, 2021 | 12,401.00 |